Lataa...
Meeting acute migraine treatment needs through novel treatment formulations
Migraineurs often do not use acute migraine-specific medications. Patient-reported satisfaction with triptans is modest. Patients are generally interested in obtaining more rapid and complete symptom relief. The role of trigeminal vascular activation may explain why some patients fail to respond to...
Tallennettuna:
| Julkaisussa: | Neurotherapeutics |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer-Verlag
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084095/ https://ncbi.nlm.nih.gov/pubmed/20430313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2010.03.004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|